40.09 USD
+0.59 (+1.49%)
Overall KEQU gets a fundamental rating of 5 out of 10. We evaluated KEQU against 187 industry peers in the Health Care Equipment & Supplies industry. KEQU has only an average score on both its financial health and profitability. KEQU has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year KEQU was profitable.
In the past year KEQU had a positive cash flow from operations.
In multiple years KEQU reported negative net income over the last 5 years.
In multiple years KEQU reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of KEQU (6.36%) is better than 85.56% of its industry peers.
The Return On Equity of KEQU (18.34%) is better than 93.58% of its industry peers.
KEQU has a Return On Invested Capital of 10.92%. This is amongst the best in the industry. KEQU outperforms 90.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KEQU is in line with the industry average of 8.81%.
The last Return On Invested Capital (10.92%) for KEQU is above the 3 year average (9.90%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROIC | 10.92% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
1.3 Margins
KEQU has a better Profit Margin (4.68%) than 75.94% of its industry peers.
KEQU has a better Operating Margin (7.60%) than 74.33% of its industry peers.
The Gross Margin of KEQU (29.37%) is worse than 77.01% of its industry peers.
In the last couple of years the Gross Margin of KEQU has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KEQU is still creating some value.
The number of shares outstanding for KEQU remains at a similar level compared to 1 year ago.
Compared to 5 years ago, KEQU has more shares outstanding
Compared to 1 year ago, KEQU has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.10 indicates that KEQU is not in any danger for bankruptcy at the moment.
KEQU has a better Altman-Z score (3.10) than 71.66% of its industry peers.
The Debt to FCF ratio of KEQU is 3.45, which is a good value as it means it would take KEQU, 3.45 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of KEQU (3.45) is better than 82.89% of its industry peers.
KEQU has a Debt/Equity ratio of 0.91. This is a neutral value indicating KEQU is somewhat dependend on debt financing.
KEQU has a Debt to Equity ratio of 0.91. This is in the lower half of the industry: KEQU underperforms 73.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Altman-Z | 3.1 |
ROIC/WACC1.4
WACC7.78%
2.3 Liquidity
A Current Ratio of 2.32 indicates that KEQU has no problem at all paying its short term obligations.
KEQU has a Current ratio of 2.32. This is comparable to the rest of the industry: KEQU outperforms 43.32% of its industry peers.
A Quick Ratio of 1.63 indicates that KEQU should not have too much problems paying its short term obligations.
KEQU has a Quick ratio of 1.63. This is comparable to the rest of the industry: KEQU outperforms 43.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 |
3. Growth
3.1 Past
The earnings per share for KEQU have decreased strongly by -33.65% in the last year.
KEQU shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.09%.
KEQU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.27% yearly.
EPS 1Y (TTM)-33.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.24%
Revenue 1Y (TTM)30.09%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.92%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 9.68, which indicates a very decent valuation of KEQU.
Based on the Price/Earnings ratio, KEQU is valued cheaper than 94.12% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.49, KEQU is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.68 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KEQU is valued cheaply inside the industry as 96.79% of the companies are valued more expensively.
KEQU's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KEQU is cheaper than 98.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.15 | ||
| EV/EBITDA | 6.2 |
4.3 Compensation for Growth
The decent profitability rating of KEQU may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
KEQU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:KEQU (12/8/2025, 2:51:58 PM)
40.09
+0.59 (+1.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners41.14%
Inst Owner Change1.56%
Ins Owners15.96%
Ins Owner Change0.44%
Market Cap115.06M
Revenue(TTM)263.18M
Net Income(TTM)12.30M
Analysts82.86
Price TargetN/A
Short Float %0.82%
Short Ratio1.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.68 | ||
| Fwd PE | N/A | ||
| P/S | 0.44 | ||
| P/FCF | 6.15 | ||
| P/OCF | 5.38 | ||
| P/B | 1.72 | ||
| P/tB | 3.1 | ||
| EV/EBITDA | 6.2 |
EPS(TTM)4.14
EY10.33%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.52
FCFY16.26%
OCF(TTM)7.45
OCFY18.57%
SpS91.7
BVpS23.37
TBVpS12.94
PEG (NY)N/A
PEG (5Y)N/A
Graham Number46.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROCE | 13.98% | ||
| ROIC | 10.92% | ||
| ROICexc | 12.63% | ||
| ROICexgc | 16.65% | ||
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% | ||
| FCFM | 7.11% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Debt/EBITDA | 2.38 | ||
| Cap/Depr | 48.41% | ||
| Cap/Sales | 1.01% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.84% | ||
| Profit Quality | 152.04% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 | ||
| Altman-Z | 3.1 |
F-Score4
WACC7.78%
ROIC/WACC1.4
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.09%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y496.38%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y2996.81%
OCF growth 3YN/A
OCF growth 5Y28.86%
KEWAUNEE SCIENTIFIC CP / KEQU FAQ
What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?
ChartMill assigns a fundamental rating of 5 / 10 to KEQU.
Can you provide the valuation status for KEWAUNEE SCIENTIFIC CP?
ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.
How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?
KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.
Can you provide the dividend sustainability for KEQU stock?
The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.